Literature DB >> 29605736

Multiple roles of lymphatic vessels in tumor progression.

Qiaoli Ma1, Lothar C Dieterich1, Michael Detmar2.   

Abstract

Sentinel lymph node metastasis is a prognostic indicator for systemic tumor spread in many types of cancers, and tumor lymphangiogenesis correlates with reduced survival. Consequently, lymphatic vessels have been suggested to promote tumor progression in multiple ways. Tumor lymphangiogenesis occurs both in primary tumors and at distant (pre-) metastatic sites, and facilitates lymphatic invasion and tumor cell dissemination. Lymphatic vessels have also emerged as regulators of tumor immunity, transporting tumor antigens to lymph nodes and directly interacting with immune cells. Furthermore, lymphatic vessels might provide a 'lymphovascular' niche contributing to the maintenance of stem-like tumor cells that are tightly related to tumor recurrence. Thus, targeting tumor lymphangiogenesis or specific lymphatic-associated functions might represent a promising approach to inhibit tumor progression.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29605736     DOI: 10.1016/j.coi.2018.03.018

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  27 in total

1.  LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C.

Authors:  Luca Ducoli; Saumya Agrawal; Eliane Sibler; Tsukasa Kouno; Carlotta Tacconi; Chung-Chao Hon; Simone D Berger; Daniela Müllhaupt; Yuliang He; Jihye Kim; Marco D'Addio; Lothar C Dieterich; Piero Carninci; Michiel J L de Hoon; Jay W Shin; Michael Detmar
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

2.  Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience.

Authors:  Barbara Peric; Sara Milicevic; Andraz Perhavec; Marko Hocevar; Janez Zgajnar
Journal:  Radiol Oncol       Date:  2020-10-08       Impact factor: 2.991

3.  CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.

Authors:  Subhashree Kumaravel; Sumeet Singh; Sukanya Roy; Lavanya Venkatasamy; Tori K White; Samiran Sinha; Shannon S Glaser; Stephen H Safe; Sanjukta Chakraborty
Journal:  Am J Pathol       Date:  2020-02-05       Impact factor: 4.307

4.  Feasibility of Shear Wave Elastography Imaging for Evaluating the Biological Behavior of Breast Cancer.

Authors:  Chaoxu Liu; Jin Zhou; Cai Chang; Wenxiang Zhi
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 5.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

6.  Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.

Authors:  Mariko Asaoka; Santosh K Patnaik; Frank Zhang; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2020-04-13       Impact factor: 4.872

7.  ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway.

Authors:  Bing Wang; Xiao-Li Zhang; Chen-Xi Li; Ning-Ning Liu; Min Hu; Zhong-Cheng Gong
Journal:  Head Face Med       Date:  2021-06-03       Impact factor: 2.151

Review 8.  Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell Trafficking.

Authors:  Jorge Arasa; Victor Collado-Diaz; Cornelia Halin
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

9.  Lymph Liquid Biopsy for Detection of Cancer Stem Cells.

Authors:  Mikyung Han; J Alex Watts; Azemat Jamshidi-Parsian; Urooba Nadeem; Eric R Siegel; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Cytometry A       Date:  2020-09-18       Impact factor: 4.714

Review 10.  Heterogeneity of tumor lymphangiogenesis: Progress and prospects.

Authors:  Xueting Hu; Jincai Luo
Journal:  Cancer Sci       Date:  2018-08-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.